This week HRH Crown Prince Frederik visited the BioInnovation Institute where 2N Pharma’s CEO Preben Bruun-Nyzell had the honour of presenting our work to develop new therapeutic medicines to treat ALS and other neurodegenerative diseases. #ALS #MND pic.twitter.com/IRiHECit4h

— 2N Pharma (@2NPharma) December 17, 2020